Albuterol/salbutamol Metered Dose Inhaler (MDI)

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 3

Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium

CompletedNCT02257385

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2014-10-15End: 2015-05-04Updated: 2018-03-01

Phase 4

A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02257372

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2014-09-30End: 2015-03-24Updated: 2017-08-17

Related Papers

Inhaler preference comparing two alternative dual bronchodilator regimens

2016-09-01

The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.

2016-06-2314 citations

Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.

2016-06-0120 citations

P124 A randomised, parallel-group study to evaluate the effect of umeclidinium added to inhaled corticosteroid/long-acting beta-agonist combination therapy in subjects with chronic obstructive pulmonary disease: Abstract P124 Table 1

Thorax2015-11-121 citations